Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Trading Statement

9 Apr 2020 07:00

RNS Number : 2822J
First Derivatives PLC
09 April 2020
 

9 April 2020

 

First Derivatives plc

("FD" or the "Group")

 

Trading Update and Notice of Results

 

FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that it continued to trade positively in the second half of the financial year ended 29 February 2020. As a result, the Board expects to report a financial performance in line with company-compiled consensus forecasts of £241m of revenue and £46m of adjusted EBITDA. Net debt at the period end was £50m, which was better than the consensus forecast of £56m.

 

COVID-19

 

The global operations of the Group enabled us to identify the business disruption threat of COVID-19 early, and we implemented our pandemic plan at the beginning of February across all regions in which we operate. A team led by CEO Seamus Keating and comprising senior leaders across FD coordinated the action, with the priorities of protecting the health and wellbeing of our employees and supporting our customers.

 

In FinTech, the Group supports mission-critical systems across the financial industry and in other markets our technology is key to the success of our customers. We contacted all our customers to minimise the impact of COVID-19 through various measures including remote working and are pleased that these are working without significant disruption to the business.

 

Impact to date

 

To date we have seen no financial impact from the effects of COVID-19. All our services delivery is now being conducted remotely, with no impact on revenue. In our managed services and consulting business the services that we provided prior to COVID-19 are now being delivered remotely with utilisation rates in March 2020 remaining in line with the prior month. We continue to monitor developments closely through close and regular contact with customers across all the markets in which we operate.

 

Potential impacts and mitigation

 

Looking ahead, our conversations with customers indicate that in the near-term there will be a lengthening of software sales cycles, at least until the impact of COVID-19 is clearer. The Group is protected to some extent by the breadth of its sales pipeline across multiple industries and geographies, while further reassurance is provided by the repeat and recurring nature of the majority of our software revenue.

 

In consulting and managed services, we continue to benefit from high levels of repeat revenue from the 'Business as Usual' operations of our capital markets clients. We are monitoring the impact of COVID-19 on new business, particularly with regard to project work implementing change programs.

 

As the macroeconomic impact of COVID-19 continues to grow, the Group has conducted a scenario testing exercise with a range of assumptions including a severe, extended downturn in economic activity. Under all such scenarios the Group remains profitable and cash generative.

 

Notwithstanding the assurance provided by our scenario testing, the Group has taken a range of measures to mitigate any future potential impact of COVID-19, including suspending non-essential business travel and short-term deferral of the summer graduate intake. In addition, the Executive Directors will not receive a bonus payment relating to the financial year ended 29 February 2020.

 

In order to preserve the Group's liquidity during this period, the Board will not recommend a final dividend in respect of the year to 29 February 2020.

 

Liquidity

 

As at 31 March 2020, FD had gross cash available to it of £64m. This included £35m of funds drawn down on 24 March 2020 from the Group's available finance facilities, with the funds placed on deposit to provide further comfort on liquidity should conditions deteriorate markedly. The Group has a further £15m in undrawn revolving credit facilities available to it.

 

The Group has significant headroom on its covenants and taking into account the scenario testing and mitigating measures taken, expects that situation to persist through the impact of COVID-19, irrespective of its duration.

 

The strength of our business model and liquidity position provide us with the confidence to continue to invest across the Group, in line with our strategy.

 

Summary

 

The Group delivered continued solid growth in the financial year to 29 February 2020. We reacted quickly to help employees and customers minimise the impact of COVID-19. While there has been no financial impact to date, it is still too early to determine what impact may result, particularly if there is an extended period of economic disruption. We believe that the Group has acted prudently to mitigate any potential impact through a range of measures aimed at ensuring its ongoing financial liquidity.

 

In the longer term, FD remains confident in its strategy and in particular the growth in demand for its world-class Kx technology from both potential customers and partners.

 

Date of results

 

The Group will announce its full year results for the year ended 29 February 2020 on 19 May 2020. A briefing for analysts and investors will be held on the day and further details will be provided in due course.

 

Enquiries

For further information please contact:

 

First Derivatives plc

Seamus Keating, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 5970

 

 

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

 

+353 1 667 0420

 

 

 

FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

 

+44 (0)20 3727 1000

 

 

About FD

FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, automotive, utility, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

 

For further information, please visit www.firstderivatives.com and www.kx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERSRITIII
Date   Source Headline
2nd Oct 20237:00 amRNSNotice of Results
31st Aug 20239:18 amRNSTotal Voting Rights
15th Aug 20237:00 amRNSIssue of Equity
31st Jul 20231:59 pmRNSTotal Voting Rights
20th Jul 20233:30 pmRNSResult of AGM
28th Jun 20234:17 pmRNSPDMR Notice and Issue of Equity
27th Jun 20234:30 pmRNSNotice of AGM
5th Jun 202312:43 pmRNSHolding(s) in Company
30th May 20231:01 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSResults for the year ended 28 February 2023
18th May 20237:00 amRNSKX partnering with Amazon Web Services
5th Apr 20237:00 amRNSLTIP Award
4th Apr 20231:51 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSFY23 trading update
20th Mar 20237:00 amRNSGeneral availability of kdb Insights Enterprise
28th Feb 20238:39 amRNSTotal Voting Rights
13th Feb 20234:43 pmRNSIssue of Equity
30th Dec 202210:06 amRNSTotal Voting Rights
22nd Dec 20224:15 pmRNSHolding(s) in Company
20th Dec 20224:02 pmRNSIssue of Equity
14th Dec 20222:01 pmRNSHolding(s) in Company
30th Nov 20228:47 amRNSTotal Voting Rights
15th Nov 20227:00 amRNSIssue of Equity
31st Oct 20227:00 amRNSDirector/PDMR Shareholding
21st Oct 202211:38 amRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSResults for the six months ended 31 August 2022
6th Oct 20222:02 pmRNSHolding(s) in Company
22nd Sep 20228:06 amRNSHolding(s) in Company
7th Sep 20227:00 amRNSNotice of Results
31st Aug 202210:09 amRNSTotal Voting Rights
16th Aug 20225:50 pmRNSIssue of Equity
5th Aug 20227:00 amRNSAppointment of Ashok Reddy as CEO of KX
2nd Aug 20229:49 amRNSHolding(s) in Company
29th Jul 202210:43 amRNSTotal Voting Rights
19th Jul 20227:00 amRNSIssue of Equity
7th Jul 20223:24 pmRNSResult of AGM
30th Jun 202212:30 pmRNSTotal Voting Rights
23rd Jun 20226:01 pmRNSIssue of Equity
8th Jun 20223:43 pmRNSNotice of AGM
31st May 202210:18 amRNSTotal Voting Rights
23rd May 20226:31 pmRNSRNS PDMR notice Issue of Equity
10th May 20227:00 amRNSResults for the year ended 28 February 2022
3rd May 20223:00 pmRNSHolding(s) in Company
26th Apr 20226:17 pmRNSHolding(s) in Company
11th Apr 20226:28 pmRNSTR1 - Notification of Major Holdings
6th Apr 20227:00 amRNSTrading update
5th Apr 20227:00 amRNSHolding(s) in Company
1st Mar 20227:00 amRNSKX Strategic Partnership Agreement with Microsoft
28th Feb 20225:52 pmRNSIssue of Equity
3rd Feb 20221:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.